Chapter 5 of the EU GMP Guide runs to 71 numbered clauses, and it's the chapter an inspector tests on your production floor. It sets the rules for how materials arrive, how batches move through processing and packaging, and what happens to anything rejected or sent back. For a Canadian Licensed Producer (LP) shipping dried flower into the EU medical channel, those clauses apply to every post-harvest step that runs under GMP.
EU-GMP Chapter 5 production controls for cannabis come down to four things: no mix-ups between cultivars or batches, a documented plan to prevent cross-contamination, verified starting and packaging materials, and reconciled quantities from receipt to release. Health Canada Good Production Practices under the Cannabis Regulations cover part of this ground. An EU auditor will test the gaps between the two systems.
What EU-GMP Chapter 5 covers for cannabis flower
Chapter 5 sits in Part I of EudraLex Volume 4, the European Commission's EU-GMP guidelines for medicinal products. Its sections run in the order a batch moves: general handling and quarantine, prevention of cross-contamination, validation, starting materials, processing, packaging materials, packaging operations, finished products, and rejected, recovered and returned materials.
Where GMP starts for dried flower
Cultivation and harvest fall under GACP, not GMP. The post-harvest steps that turn plant material into a packaged medicinal product (drying, trimming, sorting and packaging) are where German importers and authorities such as BfArM expect GMP to apply. The exact boundary belongs in your quality agreement and is shaped by the herbal product rules covered in our EU-GMP Annex 7 guide for cannabis flower.
How it compares with Health Canada GPP
Good Production Practices already require SOPs, sanitation and controlled storage. Chapter 5 goes further in four places: a formal risk assessment for cross-contamination (clause 5.20), documented supplier qualification for starting and packaging materials (5.27 and 5.45), a checklist-based line clearance before packaging (5.50), and reconciliation discrepancies investigated before release (5.61). An SOP set written only for Health Canada inspections will need rework before an EU audit.
Mix-ups and cross-contamination on the trim floor
Clause 5.9 says operations on different products shouldn't run simultaneously or consecutively in the same room unless there's no risk of mix-up or cross-contamination. On a cannabis floor, the product is the cultivar and batch. Two cultivars on neighbouring trim tables look almost identical once they're in a tote, and that's the mix-up an auditor goes looking for.
Labels on everything that holds product
Clause 5.12 requires every container, major piece of equipment and, where relevant, every room to show the material, batch number and stage of production. For flower that means drying racks, curing bins, trim totes and packaging stations all carry cultivar, batch and stage (dried, trimmed, packed). Clause 5.13 adds that colour-coded status labels (quarantined, accepted, rejected, clean) help. Use them: status should be readable from across the room.
Dust, pest control products and risk assessment
Dried flower sheds trichome dust, and clause 5.11 asks for special precautions against dust generation when handling dry materials. Clause 5.17 is blunter: pesticides and herbicides shouldn't be stored or produced in areas used to manufacture or store medicinal products. If your integrated pest management inputs sit in a cupboard inside the packaging suite, move them.
The current text dates from a revision the European Commission published on 13 August 2014, with an operational deadline of 1 March 2015. That gave manufacturers under seven months to rebuild cross-contamination control around Quality Risk Management (clauses 5.18 to 5.22). Since then, the text has required a documented risk assessment behind every cleaning SOP. The assessment decides which controls you need: dedicated equipment, local dust extraction and room pressure cascades on the technical side, campaign processing with validated cleaning and cleaning status labels on the organisational side. The premises half of that picture is in our EU-GMP Chapter 3 guide to premises and equipment.
Running two cultivars through the same trim room at the same time isn't worth the throughput. Stop doing it before your next export audit.
Starting materials, packaging and line clearance
Clauses 5.27 to 5.36 deal with starting materials, and they cover bought-in flower and packaging as well as inputs. Supplier approval has to be documented, proportionate to risk, and backed by a quality agreement that covers testing, labelling, complaints and rejection.
Bulk flower bought from another LP
Clause 5.6 says intermediate and bulk products bought in should be handled on receipt as though they were starting materials. If you buy bulk flower from another producer to fill an export order, it goes into quarantine, gets sampled and tested, and its supplier needs an approval file. A delivery made up of several batches counts as separate batches for sampling, testing and release (5.31). Clause 5.36 also asks for periodic full testing compared against the supplier's certificate of analysis, so a seller's COA alone won't carry the file. Our guide to LP-to-LP bulk sales in Canada covers the commercial side of these transactions.
Packaging and labelling materials
Pouches, jars and printed labels get the same supplier scrutiny as starting materials (5.45). Printed materials must be stored securely, issued only by authorised staff, and given a reference number for each delivery. Obsolete printed stock is destroyed and the destruction recorded (5.48), which matters every time an importer changes its label artwork.
Line clearance before every batch
Before packaging starts, clause 5.50 requires the area, line and printing equipment to be cleared of anything from the previous run, using a checklist. The product name and batch number must be displayed at each station (5.51), and on-line checks cover package appearance, completeness, correct materials and overprinting (5.59). Samples taken off the line don't go back. Keep one signed checklist per packaging run in the batch record.
Yields, rejects and returns under Chapter 5
Chapter 5 asks you to account for every gram. Yield checks and reconciliation (5.8) apply throughout, significant yield deviations are recorded and investigated (5.44), and any unusual gap between bulk flower, printed packaging and units produced must be explained before release (5.61). The same inventory numbers feed your monthly CTLS reporting to Health Canada, so a discrepancy rarely stays in one system.
Rejected material is clearly marked and stored separately in a restricted area (5.66). Reprocessing is exceptional (5.67): it's allowed only when final quality is unaffected, specifications are met and an authorised procedure follows a risk evaluation. Re-sorting or re-drying a batch that failed a specification falls into this category. Product returned from the market is destroyed unless its quality is beyond doubt (5.70). That rule covers any batch sent back after rejection at import. Each of these events opens a deviation, handled through your deviation and CAPA process.
The Chapter 5 floor audit: 7 checkpoints
| Checkpoint | Clauses | Evidence an auditor asks for |
|---|---|---|
| Status labelling | 5.12, 5.13 | Totes, racks and rooms labelled by cultivar, batch, stage |
| One batch per room | 5.9, 5.49 | Room logs with no overlapping batches |
| Cross-contamination plan | 5.20 to 5.22 | Risk assessment and periodic review record |
| Starting materials | 5.6, 5.27 to 5.36 | Supplier approvals, identity test per batch |
| Line clearance | 5.50, 5.51 | Signed checklist for each packaging run |
| Reconciliation | 5.8, 5.44, 5.61 | Yield records, investigated discrepancies |
| Rejects and returns | 5.66 to 5.70 | Segregated area, disposition records |
Process changes sit alongside these checkpoints. A new dryer or trimming method that could affect quality must be validated before use (5.25). Route those changes through change control under EU-GMP and validate them against Annex 15 qualification and validation requirements.
AlphaLeaf is a Health Canada Licensed Producer of indoor-grown, hand-trimmed cannabis flower, operating from Montreal. We hold export authorisation under the Cannabis Act and back every batch with ISO 17025-tested data and full traceability, the records EU importers need when they audit a Canadian supply partner.
Chapter 5 compliance is built shift by shift. If you're qualifying a Canadian flower supplier for the EU medical channel, talk to our team.
Frequently Asked Questions
What does EU-GMP Chapter 5 cover?
Chapter 5 of EudraLex Volume 4 sets the GMP rules for production. It covers handling and quarantine of incoming materials, prevention of mix-ups and cross-contamination, process validation, supplier and starting material control, packaging operations, finished product quarantine, and the handling of rejected, recovered and returned materials.
Does EU-GMP Chapter 5 apply to cannabis cultivation?
No. Cultivation and harvest fall under Good Agricultural and Collection Practice (GACP). Chapter 5 applies to the post-harvest steps that run under GMP, usually drying, trimming, sorting and packaging, with the exact boundary set in the quality agreement with the EU importer.
Is Health Canada GPP the same as EU-GMP Chapter 5?
No. Good Production Practices under the Cannabis Regulations cover SOPs, sanitation and storage. Chapter 5 adds a documented cross-contamination risk assessment, formal supplier qualification, checklist-based line clearance and reconciliation that must be investigated before release.
Can two cannabis cultivars be processed in the same room under EU-GMP?
Clause 5.9 says different products should not be handled simultaneously or consecutively in the same room unless there is no risk of mix-up or cross-contamination. For flower, that means one cultivar and batch per room at a time, with documented cleaning and line clearance between batches.
What is line clearance in cannabis packaging?
Line clearance is the documented check, made against a checklist, that the packaging area, line and printing equipment hold nothing from the previous run before a new batch starts. Clause 5.50 requires it, and clause 5.51 requires the product name and batch number to be displayed at each station.
Can a rejected cannabis batch be reprocessed under EU-GMP?
Only as an exception. Clause 5.67 allows reprocessing when final product quality is unaffected, specifications are met and an authorised procedure is followed after a risk evaluation, with records kept. Check whether your quality agreement also requires importer approval first.
